MSD and Schering-Plough complete global merger

MANILA, Philippines - Following the recent completion of the global merger of parent companies Merck & Co. Inc. and Schering-Plough Corp., MSD and Schering Plough (Philippines) are now in the process of integrating their respective businesses in the country.

Although MSD and Schering-Plough will remain separate legal entities for a period of time, their operations will eventually be integrated under the MSD name headed by its managing director Chris Tan.

“The Philippines is an integral part of the company’s expanded global presence and we look forward to continually meeting and exceeding the needs of customers and providing them with the high-quality products and services they have come to expect. MSD is fully committed to bringing innovative medicines and vaccines to Filipinos as well as undertaking education efforts that benefit patients and doctors and social programs that build the capacity of health professionals and NGOs to improve healthcare in the country,” Tan said.

The Merck and Schering-Plough merger has created a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long-term shareholder value.

The new company is in pole position in a wide range of areas like cardiology, infectious diseases, diabetes, respiratory, vaccines, women’s health, sun care and animal health and now the company is expanding offerings in other areas like neurology, oncology and dermatology and building new strength in categories like biologics.